Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-01 18:45:28 - browse：8

An Ozempic pen connects dots that make up the shape o a brain — coverage from STAT — ILLUSTRATION: CHRISTINE KAO/STAT; PHOTOS: ADOBE

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder.

Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious. The treatment may also fight the decline in cognitive and executive function that many people with mental health disorders experience, like worsening memory and losing the ability to focus and plan.

If further research yields positive results, it could drive even more demand for the highly popular GLP-1 treatments, which have increasingly been shown to help with problems across the body, such as heart and kidney complications. And especially if the cognitive benefits are proven out, the GLP-1 drugs would plug a critical gap in current treatments for depression, since most depression drugs help with mood, but close to none address cognitive symptoms that affect memory and attention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Virtual care provider acquires bankrupt Pear's prescription apps

WSS

Can sheer will power keep patients alive in their dying hours?

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

What STAT readers think about the FDA and patient advocacy

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

What a koala virus tells us about the human genome

Free medical tuition alone isn't enough to close gaps in primary care

leisure time

Wikipedia

knowledge

In age of alternative facts, a scholarly course on calling out crap

The United States must get value

Activists slam private health insurers over coverage restrictions

WuXi Biologics execs register to lobby as Congress comes for the company

State Dept. review finds Biden bears some blame for Afghanistan failures

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

How one medical school became remarkably diverse

Hottest summer in 2,000 years puts focus on extreme heat, health

Cancer drug shortages should be causing more outrage

CVS is willing to dump 10% of its Medicare Advantage members

entertainment

STAT series 'Denied by AI' wins major journalism prizes

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Oak Street deal isn't the answer to health care's woes

Hospitals owned by private equity see complications spike 25%

SEC charges former device maker CEO with $41 million fraud

hotspot

hotspot

hotspot

explore